{
  "input": {
    "mode": "revise",
    "query": {
      "entity": "Arrhythmogenic Right Ventricular Cardiomyopathy",
      "relation": "indication"
    },
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_amiodarone",
          "type": "Drug",
          "label": "Amiodarone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sotalol",
          "type": "Drug",
          "label": "Sotalol",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dronedarone",
          "type": "Drug",
          "label": "Dronedarone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_flecainide",
          "type": "Drug",
          "label": "Flecainide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_propafenone",
          "type": "Drug",
          "label": "Propafenone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_lidocaine",
          "type": "Drug",
          "label": "Lidocaine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_beta_blockers",
          "type": "Drug",
          "label": "Beta-blockers",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_digoxin",
          "type": "Drug",
          "label": "Digoxin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_disopyramide",
          "type": "Drug",
          "label": "Disopyramide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mexiletine",
          "type": "Drug",
          "label": "Mexiletine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_quinidine",
          "type": "Drug",
          "label": "Quinidine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_verapamil",
          "type": "Drug",
          "label": "Verapamil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target",
          "type": "Target",
          "label": "Ion Channels",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway",
          "type": "Pathway",
          "label": "Cardiac Action Potential",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_disease",
          "type": "Disease",
          "label": "Arrhythmogenic Right Ventricular Cardiomyopathy",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_amiodarone",
          "type": "Target",
          "label": "OffTarget: Amiodarone",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_sotalol",
          "type": "Target",
          "label": "OffTarget: Sotalol",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_dronedarone",
          "type": "Target",
          "label": "OffTarget: Dronedarone",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_flecainide",
          "type": "Target",
          "label": "OffTarget: Flecainide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_propafenone",
          "type": "Target",
          "label": "OffTarget: Propafenone",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_lidocaine",
          "type": "Target",
          "label": "OffTarget: Lidocaine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_betablockers",
          "type": "Target",
          "label": "OffTarget: Beta-blockers",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_digoxin",
          "type": "Target",
          "label": "OffTarget: Digoxin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_disopyramide",
          "type": "Target",
          "label": "OffTarget: Disopyramide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_mexiletine",
          "type": "Target",
          "label": "OffTarget: Mexiletine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_quinidine",
          "type": "Target",
          "label": "OffTarget: Quinidine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_verapamil",
          "type": "Target",
          "label": "OffTarget: Verapamil",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp",
          "type": "Pathway",
          "label": "Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv",
          "type": "Phenotype",
          "label": "Adverse Phenotype: Arrhythmogenic Events",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Amiodarone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Sotalol",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Dronedarone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Flecainide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Propafenone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Lidocaine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Beta-blockers",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Digoxin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Disopyramide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Mexiletine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Quinidine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Verapamil",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_amiodarone",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知药物对离子通道的影响"
        },
        {
          "source": "drug_sotalol",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知药物对离子通道的影响"
        },
        {
          "source": "drug_dronedarone",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知药物对离子通道的影响"
        },
        {
          "source": "drug_flecainide",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知药物对离子通道的影响"
        },
        {
          "source": "drug_propafenone",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "已知药物对离子通道的影响"
        },
        {
          "source": "drug_lidocaine",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "已知药物对离子通道的影响"
        },
        {
          "source": "drug_beta_blockers",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "已知药物对离子通道的影响"
        },
        {
          "source": "drug_digoxin",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "已知药物对离子通道的影响"
        },
        {
          "source": "n_target",
          "target": "n_pathway",
          "relation": "involved_in",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "离子通道在心脏电生理过程中的重要性"
        },
        {
          "source": "n_pathway",
          "target": "n_disease",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "心脏电生理异常与心脏病变相关"
        },
        {
          "source": "drug_disopyramide",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "已知药物对离子通道的影响"
        },
        {
          "source": "drug_mexiletine",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "已知药物对离子通道的影响"
        },
        {
          "source": "drug_quinidine",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "已知药物对离子通道的影响"
        },
        {
          "source": "drug_verapamil",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "已知药物对离子通道的影响"
        },
        {
          "source": "drug_amiodarone",
          "target": "H1",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "具备机制支持"
        },
        {
          "source": "drug_sotalol",
          "target": "H2",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "具备机制支持"
        },
        {
          "source": "drug_dronedarone",
          "target": "H3",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "具备机制支持"
        },
        {
          "source": "drug_flecainide",
          "target": "H4",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "具备机制支持"
        },
        {
          "source": "drug_propafenone",
          "target": "H5",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "具备机制支持"
        },
        {
          "source": "drug_lidocaine",
          "target": "H6",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "具备机制支持"
        },
        {
          "source": "drug_beta_blockers",
          "target": "H7",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "具备机制支持"
        },
        {
          "source": "drug_digoxin",
          "target": "H8",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "具备机制支持"
        },
        {
          "source": "drug_disopyramide",
          "target": "H9",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "具备机制支持"
        },
        {
          "source": "drug_mexiletine",
          "target": "H10",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "具备机制支持"
        },
        {
          "source": "drug_quinidine",
          "target": "H11",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "具备机制支持"
        },
        {
          "source": "drug_verapamil",
          "target": "H12",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "具备机制支持"
        },
        {
          "source": "drug_amiodarone",
          "target": "n_ot_amiodarone",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点机制"
        },
        {
          "source": "drug_sotalol",
          "target": "n_ot_sotalol",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点机制"
        },
        {
          "source": "drug_dronedarone",
          "target": "n_ot_dronedarone",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点机制"
        },
        {
          "source": "drug_flecainide",
          "target": "n_ot_flecainide",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点机制"
        },
        {
          "source": "drug_propafenone",
          "target": "n_ot_propafenone",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点机制"
        },
        {
          "source": "drug_lidocaine",
          "target": "n_ot_lidocaine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点机制"
        },
        {
          "source": "drug_beta_blockers",
          "target": "n_ot_betablockers",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点机制"
        },
        {
          "source": "drug_digoxin",
          "target": "n_ot_digoxin",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点机制"
        },
        {
          "source": "drug_disopyramide",
          "target": "n_ot_disopyramide",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点机制"
        },
        {
          "source": "drug_mexiletine",
          "target": "n_ot_mexiletine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点机制"
        },
        {
          "source": "drug_quinidine",
          "target": "n_ot_quinidine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点机制"
        },
        {
          "source": "drug_verapamil",
          "target": "n_ot_verapamil",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点机制"
        },
        {
          "source": "n_ot_amiodarone",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险路径"
        },
        {
          "source": "n_ot_sotalol",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险路径"
        },
        {
          "source": "n_ot_dronedarone",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险路径"
        },
        {
          "source": "n_ot_flecainide",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险路径"
        },
        {
          "source": "n_ot_propafenone",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险路径"
        },
        {
          "source": "n_ot_lidocaine",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险路径"
        },
        {
          "source": "n_ot_betablockers",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险路径"
        },
        {
          "source": "n_ot_digoxin",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险路径"
        },
        {
          "source": "n_ot_disopyramide",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险路径"
        },
        {
          "source": "n_ot_mexiletine",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险路径"
        },
        {
          "source": "n_ot_quinidine",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险路径"
        },
        {
          "source": "n_ot_verapamil",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险路径"
        },
        {
          "source": "n_rp",
          "target": "n_adv",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "导致心律失常事件"
        },
        {
          "source": "n_adv",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险存在，将抵消阿莫达酮的潜在益处"
        },
        {
          "source": "n_adv",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险存在，将抵消索他洛尔的潜在益处"
        },
        {
          "source": "n_adv",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险存在，将抵消多奈哌的潜在益处"
        },
        {
          "source": "n_adv",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险存在，将抵消氟卡尼的潜在益处"
        },
        {
          "source": "n_adv",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险存在，将抵消普鲁卡因的潜在益处"
        },
        {
          "source": "n_adv",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险存在，将抵消利多卡因的潜在益处"
        },
        {
          "source": "n_adv",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险存在，将抵消β-受体拮抗剂的潜在益处"
        },
        {
          "source": "n_adv",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险存在，将抵消地高辛的潜在益处"
        },
        {
          "source": "n_adv",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险存在，将抵消二异丙肾上腺素的潜在益处"
        },
        {
          "source": "n_adv",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险存在，将抵消美克利宁的潜在益处"
        },
        {
          "source": "n_adv",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险存在，将抵消奎尼丁的潜在益处"
        },
        {
          "source": "n_adv",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险存在，将抵消维拉帕米的潜在益处"
        }
      ],
      "round_index": 3
    },
    "history": {
      "round": 3,
      "last_scores": [
        {
          "hypothesis_id": "H1",
          "score": 0.66,
          "components": {
            "mechanism_fit": 0.8,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.6,
            "safety_risk": 0.15,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.15
          },
          "graph_signals": {
            "support_weight": 0.9,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": true,
            "path_disjointness": 4,
            "conflict_hotspots": [
              {
                "topic": "Arrhythmogenic Events",
                "pro": [
                  "H1"
                ],
                "con": [
                  "n_adv"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target（Ion Channels）→Pathway（Cardiac Action Potential）→Disease（Arrhythmogenic Right Ventricular Cardiomyopathy）的路径（由 Pro 提出）"
            ],
            "safety_risk": [
              "Skeptic 指出可能诱发心律失常事件"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "风险系统体现在离子通道和心电生理机制之间的关系还需进一步讨论"
          ]
        },
        {
          "hypothesis_id": "H2",
          "score": 0.66,
          "components": {
            "mechanism_fit": 0.8,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.6,
            "safety_risk": 0.15,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.15
          },
          "graph_signals": {
            "support_weight": 0.9,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": true,
            "path_disjointness": 4,
            "conflict_hotspots": [
              {
                "topic": "Arrhythmogenic Events",
                "pro": [
                  "H2"
                ],
                "con": [
                  "n_adv"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target（Ion Channels）→Pathway（Cardiac Action Potential）→Disease（Arrhythmogenic Right Ventricular Cardiomyopathy）的路径（由 Pro 提出）"
            ],
            "safety_risk": [
              "Skeptic 指出可能诱发心律失常事件"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "风险系统体现在离子通道和心电生理机制之间的关系还需进一步讨论"
          ]
        },
        {
          "hypothesis_id": "H3",
          "score": 0.65,
          "components": {
            "mechanism_fit": 0.75,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.65,
            "indication_plausibility": 0.65,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.2
          },
          "graph_signals": {
            "support_weight": 0.85,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": true,
            "path_disjointness": 4,
            "conflict_hotspots": [
              {
                "topic": "Arrhythmogenic Events",
                "pro": [
                  "H3"
                ],
                "con": [
                  "n_adv"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target（Ion Channels）→Pathway（Cardiac Action Potential）→Disease（Arrhythmogenic Right Ventricular Cardiomyopathy）的路径（由 Pro 提出）"
            ],
            "safety_risk": [
              "Skeptic 指出可能诱发心律失常事件"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "风险系统体现在离子通道和心电生理机制之间的关系还需进一步讨论"
          ]
        },
        {
          "hypothesis_id": "H4",
          "score": 0.61,
          "components": {
            "mechanism_fit": 0.75,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.65,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.2
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": true,
            "path_disjointness": 4,
            "conflict_hotspots": [
              {
                "topic": "Arrhythmogenic Events",
                "pro": [
                  "H4"
                ],
                "con": [
                  "n_adv"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target（Ion Channels）→Pathway（Cardiac Action Potential）→Disease（Arrhythmogenic Right Ventricular Cardiomyopathy）的路径（由 Pro 提出）"
            ],
            "safety_risk": [
              "Skeptic 指出可能诱发心律失常事件"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "风险系统体现在离子通道和心电生理机制之间的关系还需进一步讨论"
          ]
        },
        {
          "hypothesis_id": "H5",
          "score": 0.6,
          "components": {
            "mechanism_fit": 0.75,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.65,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.2
          },
          "graph_signals": {
            "support_weight": 0.75,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": true,
            "path_disjointness": 4,
            "conflict_hotspots": [
              {
                "topic": "Arrhythmogenic Events",
                "pro": [
                  "H5"
                ],
                "con": [
                  "n_adv"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target（Ion Channels）→Pathway（Cardiac Action Potential）→Disease（Arrhythmogenic Right Ventricular Cardiomyopathy）的路径（由 Pro 提出）"
            ],
            "safety_risk": [
              "Skeptic 指出可能诱发心律失常事件"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "风险系统体现在离子通道和心电生理机制之间的关系还需进一步讨论"
          ]
        },
        {
          "hypothesis_id": "H6",
          "score": 0.59,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.2
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": true,
            "path_disjointness": 4,
            "conflict_hotspots": [
              {
                "topic": "Arrhythmogenic Events",
                "pro": [
                  "H6"
                ],
                "con": [
                  "n_adv"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target（Ion Channels）→Pathway（Cardiac Action Potential）→Disease（Arrhythmogenic Right Ventricular Cardiomyopathy）的路径（由 Pro 提出）"
            ],
            "safety_risk": [
              "Skeptic 指出可能诱发心律失常事件"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "风险系统体现在离子通道和心电生理机制之间的关系还需进一步讨论"
          ]
        },
        {
          "hypothesis_id": "H7",
          "score": 0.57,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.2
          },
          "graph_signals": {
            "support_weight": 0.65,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": true,
            "path_disjointness": 4,
            "conflict_hotspots": [
              {
                "topic": "Arrhythmogenic Events",
                "pro": [
                  "H7"
                ],
                "con": [
                  "n_adv"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target（Ion Channels）→Pathway（Cardiac Action Potential）→Disease（Arrhythmogenic Right Ventricular Cardiomyopathy）的路径（由 Pro 提出）"
            ],
            "safety_risk": [
              "Skeptic 指出可能诱发心律失常事件"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "风险系统体现在离子通道和心电生理机制之间的关系还需进一步讨论"
          ]
        },
        {
          "hypothesis_id": "H8",
          "score": 0.55,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.2
          },
          "graph_signals": {
            "support_weight": 0.65,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": true,
            "path_disjointness": 4,
            "conflict_hotspots": [
              {
                "topic": "Arrhythmogenic Events",
                "pro": [
                  "H8"
                ],
                "con": [
                  "n_adv"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target（Ion Channels）→Pathway（Cardiac Action Potential）→Disease（Arrhythmogenic Right Ventricular Cardiomyopathy）的路径（由 Pro 提出）"
            ],
            "safety_risk": [
              "Skeptic 指出可能诱发心律失常事件"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "风险系统体现在离子通道和心电生理机制之间的关系还需进一步讨论"
          ]
        },
        {
          "hypothesis_id": "H9",
          "score": 0.54,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.55,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.25
          },
          "graph_signals": {
            "support_weight": 0.6,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": true,
            "path_disjointness": 4,
            "conflict_hotspots": [
              {
                "topic": "Arrhythmogenic Events",
                "pro": [
                  "H9"
                ],
                "con": [
                  "n_adv"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target（Ion Channels）→Pathway（Cardiac Action Potential）→Disease（Arrhythmogenic Right Ventricular Cardiomyopathy）的路径（由 Pro 提出）"
            ],
            "safety_risk": [
              "Skeptic 指出可能诱发心律失常事件"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "风险系统体现在离子通道和心电生理机制之间的关系还需进一步讨论"
          ]
        },
        {
          "hypothesis_id": "H10",
          "score": 0.52,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.55,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.25
          },
          "graph_signals": {
            "support_weight": 0.55,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": true,
            "path_disjointness": 3,
            "conflict_hotspots": [
              {
                "topic": "Arrhythmogenic Events",
                "pro": [
                  "H10"
                ],
                "con": [
                  "n_adv"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target（Ion Channels）→Pathway（Cardiac Action Potential）→Disease（Arrhythmogenic Right Ventricular Cardiomyopathy）的路径（由 Pro 提出）"
            ],
            "safety_risk": [
              "Skeptic 指出可能诱发心律失常事件"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "风险系统体现在离子通道和心电生理机制之间的关系还需进一步讨论"
          ]
        },
        {
          "hypothesis_id": "H11",
          "score": 0.5,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.55,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.25
          },
          "graph_signals": {
            "support_weight": 0.5,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": true,
            "path_disjointness": 3,
            "conflict_hotspots": [
              {
                "topic": "Arrhythmogenic Events",
                "pro": [
                  "H11"
                ],
                "con": [
                  "n_adv"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target（Ion Channels）→Pathway（Cardiac Action Potential）→Disease（Arrhythmogenic Right Ventricular Cardiomyopathy）的路径（由 Pro 提出）"
            ],
            "safety_risk": [
              "Skeptic 指出可能诱发心律失常事件"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "风险系统体现在离子通道和心电生理机制之间的关系还需进一步讨论"
          ]
        },
        {
          "hypothesis_id": "H12",
          "score": 0.48,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.55,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.25
          },
          "graph_signals": {
            "support_weight": 0.45,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": true,
            "path_disjointness": 3,
            "conflict_hotspots": [
              {
                "topic": "Arrhythmogenic Events",
                "pro": [
                  "H12"
                ],
                "con": [
                  "n_adv"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target（Ion Channels）→Pathway（Cardiac Action Potential）→Disease（Arrhythmogenic Right Ventricular Cardiomyopathy）的路径（由 Pro 提出）"
            ],
            "safety_risk": [
              "Skeptic 指出可能诱发心律失常事件"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "风险系统体现在离子通道和心电生理机制之间的关系还需进一步讨论"
          ]
        }
      ]
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "revisions": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "心律失常事件",
            "expectation": "如果风险存在，需要标记高权重的反对边。",
            "assignee": "Skeptic"
          },
          {
            "type": "add_mechanism_link",
            "from": "drug_amiodarone",
            "via": [
              "n_target",
              "n_pathway"
            ],
            "to": "n_disease",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "本文中药物对离子通道的影响机制与心律失常事件的关系需要进一步明确。",
          "评估药物安全性时，需给出证据支持相关风险评估。"
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "心律失常事件",
            "expectation": "如果风险存在，需要标记高权重的反对边。",
            "assignee": "Skeptic"
          },
          {
            "type": "add_mechanism_link",
            "from": "drug_sotalol",
            "via": [
              "n_target",
              "n_pathway"
            ],
            "to": "n_disease",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "药物对离子通道的影响机制的清晰度，以及与心律失常关系的有效证据。",
          "需提供数据支持药物对心律失常潜在诱发作用的真实性。"
        ]
      }
    ],
    "pruned_hypotheses": [],
    "new_subhypotheses": [],
    "seed_request": {
      "should_regenerate": false,
      "reason": "当前假设存在安全性风险与机制问题，需通过新的数据验证安全性并补充机制路径，当前不满足再生要求。",
      "n": 4
    }
  }
}